John M. Flack

24.4k total citations · 8 hit papers
216 papers, 14.0k citations indexed

About

John M. Flack is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, John M. Flack has authored 216 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Cardiology and Cardiovascular Medicine, 54 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Surgery. Recurrent topics in John M. Flack's work include Blood Pressure and Hypertension Studies (124 papers), Sodium Intake and Health (37 papers) and Hormonal Regulation and Hypertension (37 papers). John M. Flack is often cited by papers focused on Blood Pressure and Hypertension Studies (124 papers), Sodium Intake and Health (37 papers) and Hormonal Regulation and Hypertension (37 papers). John M. Flack collaborates with scholars based in United States, Australia and China. John M. Flack's co-authors include Samuel S. Gidding, Julius M. Gardin, Tom Kurosaki, Diane E. Bild, Barry J. Maron, George L. Bakris, Richard H. Grimm, Edward D. Fröhlich, Bruce Z. Morgenstern and Carlene M. Grim and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

John M. Flack

211 papers receiving 13.4k citations

Hit Papers

Prevalence of Hypertrophic Cardiomyopathy in a General Po... 1993 2026 2004 2015 1995 2014 1993 2018 2012 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Flack United States 53 8.7k 3.0k 2.3k 1.7k 1.4k 216 14.0k
Renata Cífková Czechia 37 7.9k 0.9× 2.5k 0.8× 1.8k 0.8× 1.3k 0.8× 1.8k 1.3× 217 12.3k
Suzanne Oparil United States 26 9.5k 1.1× 3.4k 1.1× 1.7k 0.7× 1.9k 1.1× 2.0k 1.5× 50 14.2k
Stanley S. Franklin United States 49 8.8k 1.0× 2.7k 0.9× 1.8k 0.8× 1.4k 0.8× 1.2k 0.8× 137 12.6k
Barry J. Materson United States 32 9.9k 1.1× 3.6k 1.2× 1.7k 0.7× 1.8k 1.1× 2.0k 1.5× 109 15.3k
Paolo Verdecchia Italy 59 12.6k 1.4× 2.5k 0.8× 2.7k 1.2× 1.5k 0.9× 646 0.5× 317 16.8k
Keith C. Ferdinand United States 50 8.0k 0.9× 2.9k 1.0× 2.4k 1.1× 1.5k 0.9× 1.5k 1.1× 267 13.0k
Michael J. Pencina United States 35 6.6k 0.8× 2.6k 0.9× 2.3k 1.0× 1.0k 0.6× 1.1k 0.8× 46 14.7k
Joseph L. Izzo United States 43 11.4k 1.3× 4.1k 1.4× 2.2k 1.0× 2.0k 1.2× 2.1k 1.5× 186 18.2k
Brent M. Egan United States 59 7.5k 0.9× 3.1k 1.0× 1.6k 0.7× 2.3k 1.4× 2.1k 1.5× 285 13.4k
Hans Ibsen Denmark 49 12.4k 1.4× 4.3k 1.4× 2.1k 0.9× 1.4k 0.9× 943 0.7× 261 16.8k

Countries citing papers authored by John M. Flack

Since Specialization
Citations

This map shows the geographic impact of John M. Flack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Flack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Flack more than expected).

Fields of papers citing papers by John M. Flack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Flack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Flack. The network helps show where John M. Flack may publish in the future.

Co-authorship network of co-authors of John M. Flack

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Flack. A scholar is included among the top collaborators of John M. Flack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Flack. John M. Flack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flack, John M., Michel Azizi, Jenifer M. Brown, et al.. (2025). Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. New England Journal of Medicine. 393(14). 1363–1374. 11 indexed citations
2.
Flack, John M., Markus P. Schlaich, Michael A. Weber, et al.. (2025). Aprocitentan for Blood Pressure Reduction in Black Patients. Hypertension. 82(4). 601–610. 2 indexed citations
3.
Flack, John M., Michael Buhnerkempe, & Kenneth Todd Moore. (2024). Resistant Hypertension: Disease Burden and Emerging Treatment Options. Current Hypertension Reports. 26(5). 183–199. 16 indexed citations
4.
Siddiqi, Tariq Jamal, Muhammad Usman, Ahmed Mustafa Rashid, et al.. (2023). Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 12(14). e029355–e029355. 15 indexed citations
5.
Levy, Phillip D., Michael J. Twiner, Aaron Brody, et al.. (2022). Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?. American Journal of Hypertension. 36(1). 50–62. 6 indexed citations
6.
Bundy, Joshua D., Mahboob Rahman, Kunihiro Matsushita, et al.. (2022). Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. Journal of the American Society of Nephrology. 33(3). 601–611. 14 indexed citations
7.
Romero, César A., Aaron Brody, Michael J. Twiner, et al.. (2021). Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy. Journal of Clinical Hypertension. 23(5). 1008–1016. 5 indexed citations
8.
Levy, Phillip D., Michael J. Twiner, Aaron Brody, et al.. (2020). Effect of Lower Blood Pressure Goals on Left Ventricular Structure and Function in Patients With Subclinical Hypertensive Heart Disease. American Journal of Hypertension. 33(9). 837–845. 3 indexed citations
9.
Ference, Brian A., et al.. (2014). Abstract 19754: Effect of Naturally Random Allocation to Lower LDL-C Mediated by Polymorphisms in NPC1L1, HMGCR or Both on the Risk of Coronary Heart Disease: a 2x2 Factorial Mendelian Randomization Study. Circulation. 130. 2 indexed citations
10.
Ference, Brian A., Wonsuk Yoo, Issa Alesh, et al.. (2012). Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease. Journal of the American College of Cardiology. 60(25). 2631–2639. 592 indexed citations breakdown →
11.
Sica, Domenic A. & John M. Flack. (2010). Treatment Considerations With Aldosterone Receptor Antagonists. Journal of Clinical Hypertension. 13(1). 65–69. 12 indexed citations
12.
Feldman, Ross D., John M. Flack, Richard Hobbs, et al.. (2009). A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin In Elderly (75 years or more) and Younger (less than 75 years) Patients: Results of a Posted Analysis of 5559 Patients. American Journal of Hypertension. 22. 12–12. 1 indexed citations
13.
Lai, Zongshan, et al.. (2009). Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clinical Endocrinology. 72(5). 595–603. 43 indexed citations
14.
Artinian, Nancy T., Richard B. Warnecke, Kimberly M. Kelly, et al.. (2007). Advancing the science of health disparities research.. PubMed. 17(3). 427–33. 6 indexed citations
15.
Artinian, Nancy T., et al.. (2006). Abstract 3307: Nurse-Managed Telemonitoring is Associated with Improved Blood Pressure at 12-Months Follow-up in African Americans. Circulation. 114. 2 indexed citations
16.
McFarlane, Samy I., Jonathan Pena Castro, John Shin, et al.. (2005). Control of Blood Pressure and Other Cardiovascular Risk Factors at Different Practice Settings: Outcomes of Care Provided to Diabetic Women Compared to Men. Journal of Clinical Hypertension. 7(2). 73–80. 45 indexed citations
17.
Flack, John M., et al.. (1996). Tolerability, safety, and quality of life and hypertensive therapy: The case for low-dose diuretics. The American Journal of Medicine. 101(3). 83S–92S. 46 indexed citations
18.
Mercuri, Michele, M. Gene Bond, Fenwick T. Nichols, et al.. (1993). Baseline reproducibility of B-mode ultrasound imaging measurements of carotid intima media thickness: the multicenter isradipine diuretic atherosclerosis study (MIDAS). 11(4). 241–256. 12 indexed citations
19.
Flack, John M. & William H. Wiist. (1991). Cardiovascular risk factor prevalence in African-American adult screenees for a church-based cholesterol education program: the Northeast Oklahoma City Cholesterol Education Program.. PubMed. 1(1). 78–90. 27 indexed citations
20.
Flack, John M., et al.. (1973). Proceedings: The use of drugs to elucidate the mechanism of luteolysis in the pseudopregnant rat. Reproduction. 35(3). 597–598. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026